This inventor holds 1 USPTO granted patent. Top assignee: Oy Juvantia Pharma Ltd.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovations of Riitta Salonen
Introduction
Riitta Salonen is a notable inventor based in Jännevirta, Finland. She has made significant contributions to the field of biotechnology, particularly in the area of genetic research. Her work focuses on the development of innovative solutions that can impact medical treatments and diagnostics.
Latest Patents
Riitta Salonen holds a patent for a DNA molecule encoding a variant α2B-adrenoceptor protein and its uses. This invention relates to a DNA sequence that comprises a nucleotide sequence encoding a variant α-adrenoceptor protein. It also includes a method for screening subjects to determine if they are carriers of a variant gene that encodes this protein. Furthermore, her invention provides a method for treating mammals suffering from vascular contraction of coronary arteries. This method involves administering a selective α-adrenoceptor antagonist to the mammal. Additionally, her work includes the development of transgenic animals that comprise a human DNA molecule encoding the human α-adrenoceptor protein or the variant α-adrenoceptor protein. She has 1 patent to her name.
Career Highlights
Riitta Salonen is associated with Oy Juvantia Pharma Ltd., where she continues to advance her research and innovations. Her career is marked by a commitment to improving healthcare through scientific discovery and application.
Collaborations
Some of her notable coworkers include Amir Snapir and Paula Heinonen, who contribute to her research endeavors and collaborative projects.
Conclusion
Riitta Salonen's work exemplifies the intersection of genetics and medicine, showcasing her innovative spirit and dedication to advancing healthcare solutions. Her contributions are paving the way for future developments in the field.